View the EROGRAN GRANULES registration information details.
Back to drug list
ItemsDrug Registration information
ID307
No307
Brand NameEROGRAN GRANULES
IngredientsERYTHOMYCIN ETHYLSUCCINATE EQ.TO ERYTHOMYCIN 200 MG/5 ML
Dosage FormGRANULES FOR SUSPENSION
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 60 ML, 100 ML/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsIN THE TREATMENT OR PROPHYLAXIS OF THE FOLLOWING: UPPER AND LOWER RESPIRATORY TRACT INFECTIONS, SKIN AND SOFT TISSUE INFECTION INCLUDING GONORRHEA AND SYPHILLIS, INTESTINAL AMOEBIASIS, OTHER INCLUDE BACTERIAL ENDOCARDITIS, TREPTOCOCCAL PHAYNGITIS, DIPHTHERIA, LEGIONNAIRES'S DISEASE AND PERTUSSIA
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE, CHERRY FLAVOURED GRANULES, PINK SUSPENSION AFTER RECONSTITUTION
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 I 5273/22
FDD Registration Date26/08/2022
Expiry Date25/08/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA